Evidence map›Paper›PMID 30230185›Full record

ReviewDiabetes, obesity & metabolism2018

Biosynthesis, structure, and folding of the insulin precursor protein.

Ming Liu, Michael A Weiss, Anoop Arunagiri, Jing Yong, Nischay Rege, Jinhong Sun, Leena Haataja, Randal J Kaufman, Peter Arvan

Open access · bronzeAbstract readReview
In one paragraph

Review in Diabetes, obesity & metabolism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 127 papers.

0numbers the graph read from it
0cells of the map it votes in
127citing papers in PubMed
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

127 citing papers in PubMed, 212 citations in OpenAlex.

  1. Review
  2. Coordinated expression and assembly of BiP, p58Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Review
  4. Article
  5. A conserved peptidase governs glucose homeostasis inbioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. SEL1L-HRD1-mediated ERAD in mammals.Nature cell biology · 2025
    Review
  19. Article
  20. Article

67 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Ming LiuDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China.
Michael A WeissDepartment of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana.ORCID 0000-0003-1325-1610
Anoop ArunagiriDivision of Metabolism, Endocrinology & Diabetes, University of Michigan Medical School, Ann Arbor, Michigan.ORCID 0000-0001-9839-1860
Jing YongDegenerative Diseases Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.
Nischay RegeDepartment of Biochemistry, Case-Western Reserve University, Cleveland, Ohio.
Jinhong SunDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China.
Leena HaatajaDivision of Metabolism, Endocrinology & Diabetes, University of Michigan Medical School, Ann Arbor, Michigan.
Randal J KaufmanDegenerative Diseases Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.ORCID 0000-0003-4277-316X
Peter ArvanDivision of Metabolism, Endocrinology & Diabetes, University of Michigan Medical School, Ann Arbor, Michigan.ORCID 0000-0002-4007-8799
University of Michigan · USSanford Burnham Prebys Medical Discovery Institute · USCase Western Reserve University · USIndiana University School of Medicine

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Proinsulin Trafficking for Insulin BiosynthesisR01DK048280 · NIDDK · YESHIVA UNIVERSITY · PI ARVAN, PETER · 1994 to 2024
$10.5M
Non-Standard Protein Design in Molecular Endocrinology: Insulin and GlucagonR01DK040949 · NIDDK · UNIVERSITY OF CHICAGO · PI CHERRINGTON, ALAN D, GEORGIADIS, MILLIE M · 1989 to 2024
$8.4M
Secretory Pathway Protein Degradation Maintains Insulin Biogenesis + SecretionR01DK111174 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ARVAN, PETER, QI, LING · 2016 to 2024
$5.5M
Modifiers of Proinsulin Influence T2D SusceptibilityR24DK110973 · NIDDK · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI ARVAN, PETER, ITKIN-ANSARI, PAMELA ROSE · 2016 to 2019
$4.1M
Mechanism of ER Protein Misfolding-Induced Mitochondrial DysfunctionR01DK113171 · NIDDK · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI KAUFMAN, RANDAL J. · 2017 to 2020
$2.5M
Design of an Implantable Pump InsulinR01DK079233 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI WEISS, MICHAEL AARON · 2008 to 2011
$1.3M
GF R01DK111174GF R01DK113171GF R01DK48280GF R24DK110973National Natural Science Foundation of China 81370895National Natural Science Foundation of China 81570699National Natural Science Foundation of China 81620108004NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK040949NIDDK NIH HHS R01 DK048280NIDDK NIH HHS R01 DK079233NIDDK NIH HHS R01 DK111174NIDDK NIH HHS R01 DK113171NIDDK NIH HHS R24 DK110973NIGMS NIH HHS T32 GM007250Tianjin Municipal Science and Technology Commission 17ZXMFSY00150U-M Protein Folding Diseases Initiative
6 · The paper itself

Abstract

Insulin synthesis in pancreatic β-cells is initiated as preproinsulin. Prevailing glucose concentrations, which oscillate pre- and postprandially, exert major dynamic variation in preproinsulin biosynthesis. Accompanying upregulated translation of the insulin precursor includes elements of the endoplasmic reticulum (ER) translocation apparatus linked to successful orientation of the signal peptide, translocation and signal peptide cleavage of preproinsulin-all of which are necessary to initiate the pathway of proper proinsulin folding. Evolutionary pressures on the primary structure of proinsulin itself have preserved the efficiency of folding ("foldability"), and remarkably, these evolutionary pressures are distinct from those protecting the ultimate biological activity of insulin. Proinsulin foldability is manifest in the ER, in which the local environment is designed to assist in the overall load of proinsulin folding and to favour its disulphide bond formation (while limiting misfolding), all of which is closely tuned to ER stress response pathways that have complex (beneficial, as well as potentially damaging) effects on pancreatic β-cells. Proinsulin misfolding may occur as a consequence of exuberant proinsulin biosynthetic load in the ER, proinsulin coding sequence mutations, or genetic predispositions that lead to an altered ER folding environment. Proinsulin misfolding is a phenotype that is very much linked to deficient insulin production and diabetes, as is seen in a variety of contexts: rodent models bearing proinsulin-misfolding mutants, human patients with Mutant INS-gene-induced Diabetes of Youth (MIDY), animal models and human patients bearing mutations in critical ER resident proteins, and, quite possibly, in more common variety type 2 diabetes.

Indexed as

AnimalsDiabetes MellitusDisease Models, AnimalEndoplasmic ReticulumHumansInsulinInsulin-Secreting CellsMiceMutationProinsulinProtein FoldingProtein PrecursorsProtein Translocation SystemsInsulinpreproinsulinProinsulinProtein PrecursorsProtein Translocation Systemsdisulphide-linked protein complexespolypeptide chain initiationSec61 transloconsecretory protein biosynthetic pathwayunfolded protein response

Identifiers

PMID30230185
PMCPMC6463291
OpenAlexW2889562110

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.